Their study also demonstrated that specific donor-recipient KIR mismatches in AML enhanced GVL effects while mitigating severe acute GVHD, reinforcing the value of integrating Cen B haplotype screening into donor selection protocols [39]. Here, KIR3DL1 is linked to acute myeloid leukemia.